Quick Answer
COLLEGIUM PHARMACEUTICAL, INC reported Gross Profit of $463.26 million for the year ending 2025.
- COLLEGIUM PHARMACEUTICAL, INC showed an increase of +22.8% in Gross Profit from 2024 to 2025.
- This data is from COLLEGIUM PHARMACEUTICAL, INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2019: $25.35 million | Q2 2019: $26.39 million | Q3 2019: $26.19 million | Q4 2019: $25.12 million | Q1 2020: $38.99 million | Q2 2020: $48.36 million | Q3 2020: $48.19 million | Q4 2020: $44.29 million | Q1 2021: $55.60 million | Q2 2021: $50.24 million | Q3 2021: $46.11 million | Q4 2021: -$1.33 million | Q1 2022: $48.50 million | Q2 2022: $52.36 million | Q3 2022: $58.84 million | Q4 2022: $49.79 million | Q1 2023: $77.40 million | Q2 2023: $73.83 million | Q3 2023: $80.31 million | Q4 2023: $94.63 million | Q1 2024: $91.46 million | Q2 2024: $90.81 million | Q3 2024: $96.79 million | Q4 2024: $98.29 million | Q1 2025: $97.32 million | Q2 2025: $108.38 million | Q3 2025: $129.17 million | Q4 2025: $128.38 million.
- Over the full 8 years of available data (2018 to 2025), COLLEGIUM PHARMACEUTICAL, INC's Gross Profit has grown by 303.8%.
- Historical annual values: Fiscal year 2025: $463.26 million | Fiscal year 2024: $377.34 million | Fiscal year 2023: $326.17 million | Fiscal year 2022: $209.49 million | Fiscal year 2021: $150.62 million | Fiscal year 2020: $179.84 million | Fiscal year 2019: $103.04 million | Fiscal year 2018: $114.74 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: